First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

​ Conditions: Lymphoblastic Lymphoma; Acute Lymphoblastic Leukemia ALL Interventions: Drug: 4A10 Sponsors: Allterum Therapeutics, Inc; National Cancer Institute (NCI); Cancer Prevention Research Institute of Texas Not yet recruiting Conditions: Lymphoblastic Lymphoma;...

Haplo-Cord HSCT for AML/MDS

​ Conditions: MDS (Myelodysplastic Syndrome); AML (Acute Myeloid Leukemia) Interventions: Procedure: haplo-cord HSCT; Drug: Fludarabine, Cytarabine, Busulfan, Antithymocyte Globulin (ATG), Melphalan, Cyclophosphamide (CTX) Sponsors: Fujian Medical University Union...